| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/12/2009 | WO2009032943A2 Methods and compositions for delivery of growth factor to fibrous connective tissue |
| 03/12/2009 | WO2009032693A2 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 03/12/2009 | WO2009030410A1 Improvements in or relating to compositions for the treatment or prophylaxis of viral infections |
| 03/12/2009 | WO2008136850A3 Cobalamin conjugates useful as imaging and therapeutic agents |
| 03/12/2009 | US20090069536 Amide Forming Chemical Ligation |
| 03/12/2009 | US20090069534 Hydrochloride salts of a glycopeptide phosphonate derivative |
| 03/12/2009 | US20090069248 Substrate peptide sequences for plague plasminogen activator and uses thereof |
| 03/12/2009 | US20090069246 Methods for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 03/12/2009 | US20090069245 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof |
| 03/12/2009 | US20090069244 Mutants of lactoferrin |
| 03/12/2009 | US20090069243 Natriuretic activities |
| 03/12/2009 | US20090069242 Therapeutically active alpha msh analogues |
| 03/12/2009 | US20090069241 Compositions and Methods for Use of Pigment Epithelial Derived Factor (PEDF) Peptide Fragments |
| 03/12/2009 | US20090069225 Somatostatin analogues |
| 03/12/2009 | US20090069224 Linear and Cyclic Melanocortin Receptor-Specific Peptidomimetics |
| 03/12/2009 | US20090069219 Deuterium-enriched telavancin |
| 03/12/2009 | US20090068736 Mutant proline-and-arginine rich peptides and methods for using the same |
| 03/12/2009 | US20090068679 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, and production and use thereof |
| 03/12/2009 | US20090068641 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 03/12/2009 | US20090068258 Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy |
| 03/12/2009 | US20090068235 Immunogenic cd19 peptides |
| 03/12/2009 | US20090068216 Modified surface antigen |
| 03/12/2009 | US20090068148 Peptides of cav2.2 that inhibit pain |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068103 Aptamers labeled with 68ga |
| 03/12/2009 | DE10149678A1 New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
| 03/12/2009 | CA2727971A1 Methods of making and using a cell penetrating peptide for enhanced delivery of nucleic acids, proteins, drugs, and adenovirus to tissues and cells, and compositions and kits |
| 03/12/2009 | CA2704729A1 Synthetic apolipoprotein e mimicking polypeptides and methods of use |
| 03/12/2009 | CA2695960A1 Vegfr-1/nrp-1 targeting peptides |
| 03/11/2009 | EP2033655A1 Use of compounds that inhibit the EF-Tu-nucleolin interaction for preventing or treating tularemia |
| 03/11/2009 | EP2033654A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/11/2009 | EP2032596A1 Neuroprotective compounds and uses thereof |
| 03/11/2009 | EP1636593B1 Modulating the interaction between hgf beta chain and c-met |
| 03/11/2009 | EP1572722B1 Recombinant biotin carboxylase domains for identification of acetyl coa carboxylase inhibitors |
| 03/11/2009 | EP1468085B1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 03/11/2009 | EP1325127B1 Method for the production of vitamin k-dependent proteins |
| 03/11/2009 | EP0977579B1 Gastrin receptor-avid peptide conjugates |
| 03/11/2009 | CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 03/11/2009 | CN101384613A Novel antimicrobial peptides and use thereof |
| 03/11/2009 | CN101381403A Alpha type conotoxin peptide derivates and use thereof |
| 03/11/2009 | CN101381402A NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 03/11/2009 | CN100467604C Chimeric GFP-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 03/11/2009 | CN100467489C Specific antibodies proBNP(1-108) for diagnosing heart failure |
| 03/11/2009 | CN100467482C New antitumoral compounds |
| 03/11/2009 | CN100467481C Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/10/2009 | US7501486 Pentapeptide having the amino acid sequence CRPPR (cysteine-arginine-proline-proline-arginine); peptides and peptidomimetics; cardiovascular disorders; drug and gene delivery |
| 03/10/2009 | US7501485 Wound heraling agents; polypeptide |
| 03/10/2009 | US7501398 Peptide; HIV-1 PR inhibitors which effectively interferes with the folding mechanism of the protein itself, thus destabilizing it and making it prone to proteolysis; acquired immune deficiency syndrome |
| 03/10/2009 | US7501397 Helical peptidomimetics with enhanced activity |
| 03/10/2009 | US7501132 Multiple antigenic peptides immunogenic against Streptococcus pneumonia |
| 03/10/2009 | CA2270408C Monoclonal antibodies against the ypydvpdya epitope, process for producing the same and their use |
| 03/05/2009 | WO2009029885A1 Treatment of autoimmune disease |
| 03/05/2009 | WO2009029716A1 Peptides inducing a cd4i conformation in hiv gp120 while retaining vacant cd4 binding site |
| 03/05/2009 | WO2009028319A1 Peptide derived from ephb6 mutant capable of binding to hla-a24 or hla-a2 molecule |
| 03/05/2009 | WO2009028248A1 Cyclic heptapeptide and use of the same |
| 03/05/2009 | WO2009027707A2 Methods for preparing peptides, especially radio-labelled peptides |
| 03/05/2009 | WO2009027706A2 Radiolabeled monomeric and multimeric cyclic oligopeptides binding to the cxcr4 receptor for cancer imaging and treatment |
| 03/05/2009 | WO2009027063A2 MUTANT DOUBLE CYCLIZED RECEPTOR PEPTIDES INHIBITING β1-ADRENOCEPTOR ANTIBODIES |
| 03/05/2009 | WO2009026729A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | WO2009026687A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/05/2009 | WO2008151257A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 03/05/2009 | WO2008113834A3 C5 antigens and uses thereof |
| 03/05/2009 | WO2007140284A4 N-terminally modified glp-1 receptor modulators |
| 03/05/2009 | WO2007072037A9 Cyclic antimicrobial peptides |
| 03/05/2009 | WO2005079300A9 Protein kinase inhibitors and methods for identifying same |
| 03/05/2009 | US20090062512 Comparative ligand mapping from MHC class I positive cells |
| 03/05/2009 | US20090062511 Process for the preparation of bivalirudin and its pharmaceutical compositions |
| 03/05/2009 | US20090062509 Chelation of metals to thiol groups using in situ reduction of disulfide-containing compounds by phosphines |
| 03/05/2009 | US20090062237 Evaluating immune competence |
| 03/05/2009 | US20090062235 Inhibitors of Dipeptidylpeptidase IV |
| 03/05/2009 | US20090062212 Peptide analogs that are potent and selective for human neurotensin preceptor subtype 2 |
| 03/05/2009 | US20090062211 Conopeptides and methods of use |
| 03/05/2009 | US20090062210 Methods for promoting erythropoiesis |
| 03/05/2009 | US20090062209 Methods of use of epsilon inhibitor compounds for the attenuation of pain |
| 03/05/2009 | US20090062207 Methods and compositions for the treatment of gastrointestinal disorders |
| 03/05/2009 | US20090062186 Compounds Binding To P-Selectin |
| 03/05/2009 | US20090062185 Deuterium-enriched anidulafungin |
| 03/05/2009 | US20090062180 Polypeptide biodrugs with given amino acid sequence which includes phosphorylated serine or threonine conjugated to a hydrophobic moiety such as a fatty acid; treating disorders such as Type II Diabetes, neurodegenerative diseases and psychological disorders |
| 03/05/2009 | US20090062178 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 03/05/2009 | US20090062150 Compositions and methods for regulating intramembrane proteases |
| 03/05/2009 | US20090061498 Polyhydroxyalkanoate-containing structure and manufacturing method thereof |
| 03/05/2009 | US20090061014 Synthetic peptide and peptide conjugates and related tissue coupling methods via transglutaminase enzyme |
| 03/05/2009 | US20090060947 Immunological compositions |
| 03/05/2009 | US20090060934 S. agalactiae antigens i & ii |
| 03/05/2009 | US20090060929 Gene therapy and vaccination; non-viral transfection complex of a nucleic acid, optionally, a lipid,a polycationic nucleic acid-binding component, and a cell surface receptor binding peptide of given sequence |
| 03/05/2009 | US20090060904 Vegetarian Protein A Preparation and Methods Thereof |
| 03/05/2009 | US20090060888 Regulated transcription of targeted genes and other biological events |
| 03/05/2009 | US20090060864 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 03/05/2009 | CA2698115A1 Treatment of autoimmune disease |
| 03/05/2009 | CA2697951A1 Amino acid pairing-based self assembling peptides and methods |
| 03/05/2009 | CA2697949A1 Cancer imaging and treatment |
| 03/05/2009 | CA2697108A1 Mutant double cyclized receptor peptides inhibiting .beta.1-adrenoceptor antibodies |
| 03/05/2009 | CA2695559A1 Neuroprotection using nap-like and sal-like peptide mimetics |
| 03/04/2009 | EP2030628A1 A peptide for preventing or treating liver damage and its derivant and the use |
| 03/04/2009 | EP2029618A2 Agents, methods and uses |
| 03/04/2009 | EP2029060A1 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 03/04/2009 | EP1401863B1 Somatostatin-dopamine chimeric analogs |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1064300B1 Peptide turn mimetics |